23.60
-0.25
(-1.05%)
At close: 1:30:38 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-44,480
-44,480
-69,369
-52,891
-29,181
Investing Cash Flow
2,734
2,734
20,445
-1,137
-104,820
Financing Cash Flow
-9,888
-9,888
-5,895
-13,156
-4,162
End Cash Position
83,793
83,793
133,893
189,480
255,659
Capital Expenditure
-3,801
-3,801
-2,013
-1,093
-8,430
Free Cash Flow
-48,281
-48,281
-71,382
-53,984
-37,611
12/31/2021 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3118.TWO Level Biotechnology Inc.
31.35
-0.95%
4130.TWO Genovate Biotechnology Co., Ltd.
20.25
-1.22%
4168.TWO GlycoNex Incorporation
16.95
-0.59%
3176.TWO Medigen Biotechnology Corp.
30.20
+3.07%
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
88.10
-0.56%
6492.TWO Senhwa Biosciences, Inc.
32.75
-2.24%
4192.TWO SynCore Biotechnology Co.,Ltd
27.90
+1.45%
4147.TWO TaiMed Biologics Inc.
78.90
+1.41%
6461.TWO Intech Biopharm Corporation
18.90
-0.53%
4174.TWO OBI Pharma, Inc.
47.50
-3.16%